Osteoarthritis and diet: Joined at the hip - Veterinary Medicine
Medicine Center
DVM Veterinary Medicine Featuring Information from:


Osteoarthritis and diet: Joined at the hip

Clinical Edge

40. Drevon, C.A.: Marine oils and their effects. Nutr. Rev. 50 (4):38-45; 1992.

41. Schoenherr, W.D.; Jewell, D.E.: Nutritional modification of inflammatory diseases. Semin. Vet. Med. Surg. (Sm. Anim.) 12 (3):212-222; 1997.

42. Waldron, M.K. et al.: Neutrophil leukotriene synthesis and superoxide production are differentially modulated by type and amount of dietary n-3 polyunsaturated fatty acids. Am. Oil Chem. Soc. S118(Abstr); 2000.

43. Curtis, C.L. et al.: Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. Arthritis Rheum. 46 (6):1544-1553; 2002.

44. Watkins, B.A. et al.: Omega-3 polyunsaturated fatty acids and skeletal health. Exp. Biol. Med. 226 (6):485-497; 2001.

45. Richardson, D.C. et al.: Nutritional management of osteoarthritis. Vet. Clin. North Am. 27 (4):883-911; 1997.

46. Miller, W.H. et al.: Treatment of dogs with hip arthritis with a fatty acid supplement. Canine Pract. 17 (6):6-8; 1992.

47. Hansen, R.A. et al.: Long chain n-3 PUFA improve biochemical parameters associated with canine osteoarthritis. Proc. AOCS, AOCS, Cincinnati, Ohio, 2004.

48. Deal, C.L.; Moskowitz, R.W.: Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum. Dis. Clin. North Am. 25 (2):379-395; 1999.

49. Anderson, M.A.: Oral chondroprotective agents. Part I. Common compounds. Compend. Cont. Ed. 21 (7):601-609; 1999.

50. Richy, F. et al.: Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: A comprehensive meta-analysis. Arch. Intern. Med. 163 (13):1514-1522; 2003.

51. Canapp, S.O. Jr. et al.: Scintigraphic evaluation of dogs with acute synovitis after treatment with glucosamine hydrochloride and chondroitin sulfate. Am. J. Vet. Res. 60 (12):1552-1557; 1999.

52. Chen, J.R. et al.: Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford) 38 (12):1275-1278; 1999.

53. Hay, C.W. et al.: Synovial fluid interleukin 6, tumor necrosis factor, and nitric oxide values in dogs with osteoarthritis secondary to cranial cruciate ligament rupture. AJVR 58 (9):1027-1032; 1997.

54. Lunec, J. et al.: Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J. Rheumatol. 8 (2):233-245; 1981.

55. Mazzetti, I. et al.: Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin. Sci. (Lond) 101 (6):593-599; 2001.

56. Yudoh, K. et al.: Oxidative stress induces chondrocyte telomere instability and chondrocyte dysfunctions in osteoarthritis. Arthritis Res. Ther. (suppl. 3):164; 2003.


Source: Clinical Edge,
Click here